S2.5d Exploring multidrug resistance, fitness compensation, and collateral sensitivity in Candida auris : Fight fire with fire?

S2.5 RARE YEASTS, SEPTEMBER 21, 2022, 3:00 PM - 4:30 PM: Candida auris (C. auris) is a recently emerged human fungal pathogen of growing concern due to its ability to acquire extensive multidrug resistance (MDR) to all four antifungal drug classes. The unprecedented extent of MDR in C. auris, sugges...

Descripción completa

Detalles Bibliográficos
Autores principales: Carolus, Hans, Sofras, Dimitrios, Sephton-Clark, Poppy, Goossens, Louise, Chen, Alicia, Pierson, Siebe, Romero, Celia Lobo, Subotić, Ana, Meis, Jacques F., Cuomo, Christina A., Van Dijck, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Oral Presentations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515916/
http://dx.doi.org/10.1093/mmy/myac072.S2.5d

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515916/
http://dx.doi.org/10.1093/mmy/myac072.S2.5d

Ejemplares similares